NYU Langone
Videos
NYU Langone
FDA Approval of Adagrasib in KRAS G12Cm NSCLC
FEATURING
Joshua Sabari
- 356 views
- December 16, 2022
- 2
NYU Langone
Treatment Questions for Medical Oncologists Treating Melanoma
FEATURING
Jeffrey Weber
- 201 views
- November 18, 2022
NYU Langone
TPO-RA Agents in Children With ITP: What to Consider in Terms of Timing and Rationale
FEATURING
Kirsty Hillier
- 21 views
- October 11, 2022
- 1
NYU Langone
Case Presentation on HER2+ Breast Cancer: Adapting Patient Care to a Rapidly Evolving Treatment Landscape
FEATURING
Douglas Marks
- 230 views
- September 13, 2022
- 1
NYU Langone
The Great Debate: Is Neoadjuvant Therapy Really Better Than Adjuvant Therapy in Melanoma?
FEATURING
Jeffrey Weber
- 330 views
- September 23, 2021
NYU Langone
Adjuvant and Neoadjuvant Melanoma Dilemmas: Considering Treatment Outcomes With IO and Targeted Therapy Agents
FEATURING
Jeffrey Weber
- 374 views
- May 20, 2021
- 1
NYU Langone
2020 CheckMate 238 Update on IO in Advanced Stage Melanoma: Did Nivo Show Sustained Superior Patient Benefit vs. Ipi in High-Risk Resected Disease?
FEATURING
Jeffrey Weber
- 1,135 views
- November 9, 2020
- 2